Prostatis Group’s Innovator Equity Defined Protection ETF - 1 Yr February ZFEB Stock Holding History

Prostatis Group’s Portfolio ZFEB Stock Details ZFEB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$448K	Sell	17,256 -760	-4%	-$19.6K	0.1%	113
2026 Q1	$457K	Sell	18,016 -33,329	-65%	-$849K	0.12%	109
2025 Q4	$1.3M	Sell	51,345 -38,678	-43%	-$972K	0.31%	65
2025 Q3	$2.25M	Sell	90,023 -16,235	-15%	-$400K	0.56%	47
2025 Q2	$2.59M	Buy	106,258 +95,326	+872%	+$2.28M	0.74%	39
2025 Q1	$259K	Buy	+10,932	New	+$260K	0.08%	132

Other funds holding ZFEB

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

ABWM

Alpine Bank Wealth Management Grand Junction, Colorado $779M AUM 19.75% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

AAS

Ameritas Advisory Services Lincoln, Nebraska $4.96B AUM 27.52% 1-Year Est. Return

NovaPoint Capital Atlanta, Georgia $481M AUM 32.01% 1-Year Est. Return

Prostatis Group's ZFEB Position: Q2 2026 in Review

Prostatis Group reduced its Innovator Equity Defined Protection ETF - 1 Yr February (ZFEB) stake by 4.2% in Q2 2026, selling an estimated $19.6K and leaving 17,256 shares worth $448K. The position accounts for 0.1% of the portfolio, ranked #113.

Prostatis Group first reported a position in ZFEB in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.59M in Q2 2025. 103 funds tracked by Wall St. Rank hold ZFEB as of Q2 2026.

Prostatis Group held 17,256 shares of Innovator Equity Defined Protection ETF - 1 Yr February worth $448K as of Q2 2026.
Prostatis Group sold 760 Innovator Equity Defined Protection ETF - 1 Yr February shares in Q2 2026, an estimated $19.6K.
Innovator Equity Defined Protection ETF - 1 Yr February made up 0.1% of Prostatis Group's portfolio in Q2 2026, its #113 holding.
Prostatis Group first reported a position in Innovator Equity Defined Protection ETF - 1 Yr February in Q1 2025 and has held it in 6 quarters since.
Prostatis Group's Innovator Equity Defined Protection ETF - 1 Yr February position peaked at $2.59M in Q2 2025.
103 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 1 Yr February as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.